Köse Çınar R.2024-06-122024-06-1220161172-0360https://doi.org/10.1007/s40267-016-0328-zhttps://hdl.handle.net/20.500.14551/16124Data on the safety of antipsychotic use during pregnancy remain inconclusive. Here, we report the history of a woman with schizophrenia who had two pregnancies while receiving prolactin-sparing antipyschotic drugs. The case supports existing data showing that the use of olanzapine and clozapine (on separate occasions) during pregnancy results in uncomplicated deliveries of healthy infants. © 2016, Springer International Publishing Switzerland.en10.1007/s40267-016-0328-zinfo:eu-repo/semantics/closedAccessClozapine; Olanzapine; Risperidone; Adult; Article; Auditory Hallucination; Bipolar Disorder; Case Report; Cesarean Section; Delusion; Disease Exacerbation; Drug Dose Increase; Drug Substitution; Drug Withdrawal; Female; Hebephrenia; Hospital Admission; Human; Hyperprolactinemia; Mania; Negative Syndrome; Optimal Drug Dose; Paranoia; Schizophrenia; Treatment Duration; Treatment Refusal; Unplanned Pregnancy; Young AdultArticle3294034052-s2.0-84983432398Q4